SCHEMBL6948431

SCHEMBL6948431

CN(C)C1CC(=O)CCC1N(C)C(=O)Cc1ccc(Br)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 10/20 0.54
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
CCR5 P51681 1/20 0.43
OPRK1 P41145 4/20 0.36
OPRM1 P35372 2/20 0.36
TP53 P04637 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 2/20 0.36
TSHR P16473 2/20 0.36
ALDH1A1 P00352 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
MTOR P42345 1/20 0.36
RAB9A P51151 1/20 0.36
OPRD1 P41143 1/20 0.36
MAPK8 P45983 1/20 0.36
MAPK9 P45984 1/20 0.36
MAPK10 P53779 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9699975 0.83 SIGMAR1 (0.70) SIGMAR1MEN1KMT2ACCR5OPRK1
Hydrochloric Acid SCHEMBL11529411 0.82 SIGMAR1 (0.69) SIGMAR1MEN1KMT2ACCR5OPRK1
SCHEMBL11526101 0.82 SIGMAR1 (0.69) SIGMAR1MEN1KMT2ACCR5OPRK1
SCHEMBL11533330 0.82 SIGMAR1 (0.69) SIGMAR1MEN1KMT2ACCR5OPRK1
SCHEMBL10832891 0.82 SIGMAR1 (0.59) SIGMAR1MEN1KMT2ACCR5OPRK1
SCHEMBL11246776 0.80 SIGMAR1 (0.44) SIGMAR1MEN1KMT2AOPRK1OPRM1
Maleic Acid SCHEMBL11532370 0.76 SIGMAR1 (0.61) SIGMAR1MEN1KMT2ACCR5OPRK1
Fumaric Acid SCHEMBL11532376 0.76 SIGMAR1 (0.61) SIGMAR1MEN1KMT2ACCR5OPRK1
SCHEMBL11530369 0.70 SIGMAR1 (1.00) SIGMAR1MEN1KMT2AOPRK1OPRM1
Hydrochloric Acid SCHEMBL11530039 0.69 SIGMAR1 (0.56) SIGMAR1MEN1KMT2AOPRK1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2003526594-A 2003-09-09 JP claimed
EP-0996434-A4 KAPPA AGONIST ANTI-PRURITIC PHARMACEUTICAL FORMULATIONS AND METHOD OF TREATING PRURITUS THEREWITH ADOLOR CORP (US) 2001-10-10 EP claimed
EP-0996434-A1 KAPPA AGONIST ANTI-PRURITIC PHARMACEUTICAL FORMULATIONS AND METHOD OF TREATING PRURITUS THEREWITH Adolor Corporation (US) 2000-05-03 EP claimed
WO-1999003459-A1 KAPPA AGONIST ANTI-PRURITIC PHARMACEUTICAL FORMULATIONS AND METHOD OF TREATING PRURITUS THEREWITH ADOLOR CORPORATION (US) 1999-01-28 WO claimed
EP-0996434-A4 KAPPA AGONIST ANTI-PRURITIC PHARMACEUTICAL FORMULATIONS AND METHOD OF TREATING PRURITUS THEREWITH ADOLOR CORP (US) 2001-10-10 EP disclosed
US-6156769-A Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith APOLOR CORP. (US) 2000-12-05 US disclosed
EP-0996434-A1 KAPPA AGONIST ANTI-PRURITIC PHARMACEUTICAL FORMULATIONS AND METHOD OF TREATING PRURITUS THEREWITH Adolor Corporation (US) 2000-05-03 EP disclosed
US-6048860-A Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith ADOLOR CORPORATION (US) 2000-04-11 US disclosed
US-6004964-A ADMINISTERING AMIDE OR SULFONAMIDE DERIVATIVE; ANALGESICS ADOLOR CORPORATION (US) 1999-12-21 US disclosed
US-5869521-A Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith ADOLOR CORPORATION (US) 1999-02-09 US disclosed
WO-1999003459-A1 KAPPA AGONIST ANTI-PRURITIC PHARMACEUTICAL FORMULATIONS AND METHOD OF TREATING PRURITUS THEREWITH ADOLOR CORPORATION (US) 1999-01-28 WO disclosed
US-5760023-A CYCLOHEXYLACETAMIDE DERIVATIVES, AGONIST AT KAPPA OPIOD RECEPTORS, TREATMENT OF ITCHING ADOLOR CORPORATION (US) 1998-06-02 US disclosed
US-4360531-A Substituted cycloalkanes THE UPJOHN COMPANY (US) 1982-11-23 US disclosed